Free Trial
OTCMKTS:DMTTF

Small Pharma (DMTTF) Stock Price, News & Analysis

Small Pharma logo
$0.11 0.00 (0.00%)
As of 10/25/2023

About Small Pharma Stock (OTCMKTS:DMTTF)

Key Stats

Today's Range
$0.11
$0.11
50-Day Range
$0.11
$0.11
52-Week Range
$0.05
$0.19
Volume
N/A
Average Volume
113,204 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom.

Receive DMTTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

DMTTF Stock News Headlines

Top 5 Small-cap Pharma Stocks in 2025
Urgent: Make this trade before you hit your pillow tonight…
Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they wish they could live. But thanks to a little-known “loophole” in the markets after midnight...
See More Headlines

DMTTF Stock Analysis - Frequently Asked Questions

Small Pharma's stock was trading at $0.1117 at the beginning of the year. Since then, DMTTF stock has increased by 0.0% and is now trading at $0.1117.
View the best growth stocks for 2025 here
.

Shares of DMTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:DMTTF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:DMTTF) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners